SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001855763-22-000019
Filing Date
2022-10-18
Accepted
2022-10-18 18:20:31
Documents
1
Period of Report
2022-10-12

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4/A  
1 PRIMARY DOCUMENT primary_doc.xml 4/A 6461
  Complete submission text file 0001855763-22-000019.txt   7963
Mailing Address 1924 BIRKDALE AVE KELOWNA A1 V1P1R7
Business Address
BUNKA CHRISTOPHER (Reporting) CIK: 0001103780 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-39874 | Film No.: 221316860

Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Issuer) CIK: 0001348362 (see all company filings)

IRS No.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
SIC: 2834 Pharmaceutical Preparations